C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/16/2004	WO2004108065A2 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
12/16/2004	WO2004099400A3 Variant lipolytic ensymes
12/16/2004	WO2004096844A3 Group 1 mite polypeptide variants
12/16/2004	WO2004094635A3 Compositions and methods for using a solid support to purify rna
12/16/2004	WO2004093532A3 Generation of plants with altered oil content
12/16/2004	WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift
12/16/2004	WO2004089072A3 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene
12/16/2004	WO2004087960A3 Method and system for rapidly conferring a desired trait to an organism
12/16/2004	WO2004087766A3 Peptabody for cancer treatment
12/16/2004	WO2004080448A3 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases
12/16/2004	WO2004078945A3 Nucleotide sequences of 2s albumin gene and its promoter from grape and uses thereof
12/16/2004	WO2004078940A3 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1
12/16/2004	WO2004078911A3 T-cell transformation by recombinant hvs subgroup c
12/16/2004	WO2004078905A8 Agents for phytoremediation
12/16/2004	WO2004076659A3 Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways
12/16/2004	WO2004075861A3 Recombinant adeno-associated virus production
12/16/2004	WO2004074443A3 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps)
12/16/2004	WO2004074430A3 Compositions, splice variants and methods relating to lung specific genes and proteins
12/16/2004	WO2004072252A3 Polymerase-based protocols for the introduction of deletions and insertions
12/16/2004	WO2004072245A3 Polymerase-based protocols for the introductions of deletions and insertions
12/16/2004	WO2004070035A3 Method for increasing efficiency of homologous recombination in plants
12/16/2004	WO2004064500A3 Transcriptional coactivator asc-2
12/16/2004	WO2004062602A3 Compositions and methods for targeted biological delivery of molecular carriers
12/16/2004	WO2004052297A3 TREATMENT OF HSV-RELATED PATHOLOGIES USING ssDNA
12/16/2004	WO2004046336A3 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway
12/16/2004	WO2004035731A3 Increasing host plant susceptibility to agrobacterium infection by overexpression of the arabidopsis vip1 gene
12/16/2004	WO2004033622A9 Preservation of rna and morphology in cells and tissues
12/16/2004	WO2004029253A3 Nucleic acid sequences coding for proteolytic enzymes in the form of specific proteases, corresponding polypeptides and use of the same
12/16/2004	WO2004029218A3 Receptors and membrane-associated proteins
12/16/2004	WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
12/16/2004	WO2004011608A3 Methods and nucleic acid vectors for rapid expression and screening of cdna clones
12/16/2004	WO2004009790A3 Metastatic colon cancer specific promoter and uses thereof
12/16/2004	WO2004003156A3 Il-21 as a regulator of immunoglobin production
12/16/2004	WO2003092582B1 Chimeric ebola virus envelopes and uses therefor
12/16/2004	WO2003090514A8 Adipocyte complement related protein zacrp14
12/16/2004	WO2003087115B1 Oligomeric compounds having modified phosphate groups
12/16/2004	WO2003080823A8 Bacteriophages useful for therapy and prophylaxis of bacterial infections
12/16/2004	WO2003080809A3 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
12/16/2004	WO2003066802A9 Gene expression analysis using nicking agents
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	WO2003057833A3 Mutant chromophores/fluorophores and methods for making and using the same
12/16/2004	WO2003054184A9 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease
12/16/2004	WO2003027254A3 15625 receptor, a novel g-protein coupled receptor
12/16/2004	WO2003005953A3 Viral proteins capable of binding lar
12/16/2004	WO2002070665A8 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
12/16/2004	WO2001062892A3 Method for ligating nucleic acids and molecular cloning
12/16/2004	US20040255353 Inbred corn line W69079
12/16/2004	US20040255352 Transgenic seeds for propagation of male sterile disease, insect, drought, hebicide and heat resistant plants with enhanced carbohydrate and fatty acid metabolism; improving nutrient quality of crop plants
12/16/2004	US20040255351 Protein associated with homologous recobination for use as gene insertion tool in generating transgenic plants; bioreactors and heterologous gene expression
12/16/2004	US20040255350 Flax seed specific promoters
12/16/2004	US20040255349 Plant flower type targeting mads box gene
12/16/2004	US20040255348 Nucleotide sequences coding viral promoter sequences for use in detection of viral infection in plants; regulatory elements for expression of heterologous genes in cells
12/16/2004	US20040255347 Using site specific recombination to insert heterologous nucleotide sequences into plants tissue; enhancing nutrient quality of plants; bioreactors
12/16/2004	US20040255346 Transgenic plants over-expressing a heat shock factor
12/16/2004	US20040255344 Rodent with urinary disturbance and method of constructing the same, and method of screening remedy for urinary disturbance using the rodent
12/16/2004	US20040255343 Caspase-9 deficient animals and the use thereof
12/16/2004	US20040255342 Animal model for identifying modulator to treat and/or prevent alzheimer's disease
12/16/2004	US20040255341 Transgenic flies expressing Abeta42-Arctic
12/16/2004	US20040254364 Phage display of a biologically active Bacillus thuringiensis toxin
12/16/2004	US20040254363 Genes and snps associated with eating disorders
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254361 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof
12/16/2004	US20040254360 Molecular identification of staphylococcus-type bacteria
12/16/2004	US20040254359 Antisense modulation of stearoyl-coa desaturase expression
12/16/2004	US20040254355 Labeling reagents comprising aphenylic analogs of rhodamine dyes
12/16/2004	US20040254351 Hyperglycosylated polypeptides
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254349 Mycobacterial antigens expressed under low oxygen tension
12/16/2004	US20040254348 Opiate receptor therapeutic protein/peptides for use in pain relief and management
12/16/2004	US20040254346 Human survivin interacting protein 1 (sip-1)
12/16/2004	US20040254342 Substrates and assays for beta-secretase
12/16/2004	US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors
12/16/2004	US20040254235 homoserine lactone derivatives that stimulate or promote the metabolism, growth and/or recovery of microorganisms
12/16/2004	US20040254140 Method for selective inactivation of viral replication
12/16/2004	US20040254139 Dna sequences, Rna sequences; binding to tumor necrosis factor
12/16/2004	US20040254138 Vectors containing genomic Dna, Rna encoding replacement gene; bone disordwers; vision defects; antidepressants; anticancer agents
12/16/2004	US20040254137 Nucleotide sequences; for therapy of bone disorders, chondrondysplasis; biodrug; activation caspase signaling cascade
12/16/2004	US20040254136 Antisense oligonucleotides and related methods for regulating cell death
12/16/2004	US20040254135 Administering enzyme inhibitor; moderate metabolism
12/16/2004	US20040254134 Modulating heart cells; administering polynucleotide; adjust contraction
12/16/2004	US20040254133 Autoimmune disease; antidiabetic agents; multiple sclerosis; antiarthritic agents; Crohn's disease
12/16/2004	US20040254132 Ovary-specific genes and proteins
12/16/2004	US20040254131 Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels
12/16/2004	US20040254114 Genetic engineering
12/16/2004	US20040254110 Methods for diagnosing and treating Alzheimer's disease
12/16/2004	US20040254106 Modified factor ix
12/16/2004	US20040254105 recombinant vectors and recombinant host cells
12/16/2004	US20040253732 Transposon vector which utilizes recombinase for transfer and propagation of heterologous nucleotide sequences
12/16/2004	US20040253731 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells
12/16/2004	US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders
12/16/2004	US20040253729 Circular site-directed mutagenesis
12/16/2004	US20040253728 New method
12/16/2004	US20040253727 Using both insertional and physiochemical means to generate stable, genetic rearrangement in cells; tissue engineering
12/16/2004	US20040253723 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/16/2004	US20040253720 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
12/16/2004	US20040253717 Rice sucrose tranporter gene promoter
12/16/2004	US20040253713 Ethanol production
12/16/2004	US20040253711 Mycobacterial genes down-regulated during latency
12/16/2004	US20040253710 Transgenic escherichia for which express bacterial surface protein for use in generation of vaccine which prevents coliform bacterial infection; antidiarrhea agents
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases

1 ... 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 ... 4023